Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Standardized delivery room management for neonates with a prenatal diagnosis of congenital heart disease: A model for improving interdisciplinary delivery room care.

Journal of neonatal-perinatal medicine·2020
Same author

Why the Public Need a Say in How Patient Data are Used for Covid-19 Responses.

International journal of population data science·2020
Same author

Elective neck dissection for the node-negative neck during salvage laryngectomy: an analysis of survival outcomes and complication rates.

The Journal of laryngology and otology·2019
Same author

Genomic analysis to assess disease progression and recurrence in patients with oral squamous cell carcinoma: - a preliminary study.

The British journal of oral & maxillofacial surgery·2018
Same author

Twelve-month prevalence and treatment gap for common mental disorders: Findings from a large-scale epidemiological survey in India.

Indian journal of psychiatry·2017
Same author

Local Anaesthesia for Fiberoptic Intubation : A Comparison of Three Techniques.

Medical journal, Armed Forces India·2016
Same journal

Anemia associated with long-acting injectable aripiprazole in an elderly man.

Indian journal of psychiatry·2026
Same journal

Psychiatric comorbidities and treatment patterns in epilepsy: A retrospective review from a tertiary neuropsychiatric clinic.

Indian journal of psychiatry·2026
Same journal

Proposal of 'World Psychiatry Day': The aim is to celebrate psychiatry as the third division of medicine alongside internal medicine and general surgery.

Indian journal of psychiatry·2026
Same journal

A bibliometric assessment of the <i>Indian Journal of Psychiatry</i>: Trends, impact, and collaboration (2009-2024).

Indian journal of psychiatry·2026
Same journal

Narcotic bowel syndrome misdiagnosed as somatoform pain disorder and presenting with opioid use disorder - A case report.

Indian journal of psychiatry·2026
Same journal

From tramadol to pregabalin addiction: A case report of unsupervised substance substitution and temporally improved in craving with fluoxetine.

Indian journal of psychiatry·2026
See all related articles

Related Experiment Video

Updated: May 29, 2026

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes
15:43

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes

Published on: January 7, 2013

Lithium and renal functions.

N Sethi1, J K Trivedi, B B Sethi

  • 1Scientist, Central Drug Research Institute, Lucknow.

Indian Journal of Psychiatry
|September 20, 2011
PubMed
Summary
This summary is machine-generated.

Lithium therapy for affective disorder does not impair kidney function over one year. This study found no significant deterioration in renal functions for patients on lithium compared to those on antidepressants.

Related Experiment Videos

Last Updated: May 29, 2026

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes
15:43

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes

Published on: January 7, 2013

Area of Science:

  • Nephrology
  • Psychiatry
  • Pharmacology

Background:

  • Affective disorders require long-term treatment.
  • Lithium and antidepressants are common pharmacotherapies.
  • Renal function is a critical consideration for long-term medication safety.

Purpose of the Study:

  • To evaluate the long-term impact of lithium therapy on renal functions.
  • To compare renal function changes in patients on lithium versus antidepressants.

Main Methods:

  • A comparative study involving 60 patients with affective disorder.
  • Patients were divided into two groups: 30 on lithium and 30 on antidepressants for one year.
  • Detailed assessment of renal functions was performed for all participants.

Main Results:

  • Lithium therapy did not result in any observed deterioration of kidney functions.
  • No significant difference in renal function decline was noted between the lithium and antidepressant groups.

Conclusions:

  • Long-term lithium treatment appears safe for renal function in patients with affective disorder.
  • This finding supports the continued use of lithium as a viable treatment option, with careful monitoring.